DrugBiological

Pegylated Interferon Alfa clinical trials

studies test it: 14
open now: 1
in phase 3: 1
first study started: 1998

Keep track of what changes. Save the Pegylated Interferon Alfa studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

pegylated interferon alfa: 6
peginterferon alfa: 6
peginterferon alfa-2a or peginterferon alfa-2b: 2

Combined with it in one product

PEG-Interferon Alfa, Tenofovir Disoproxil Fumarate: 1

Studies by the year they started

14 studies that test it; most in 2016 (4)

Studies that test Pegylated Interferon Alfa, by start year
Year	Studies
1998	1
1999	1
2000	1
2002	1
2005	1
2011	1
2016	4
2018	1
2019	1
2021	1
2024	1

By phase

A phase 1/2 study counts in both.

Phase 1: 2
Phase 2: 5
Phase 3: 1
Phase 4: 7

What it is tested for

Each study’s main condition, where its own words name it.

Hepatitis B, Chronic: 6
Carcinoma, Renal Cell: 1
Lymphoma, Non-Hodgkin: 1
Diffuse Intrinsic Pontine Glioma: 1
Hepatitis C, Chronic: 1
Melanoma: 1

Who runs them

Industry 3 · Other 11

Third Affiliated Hospital, Sun Yat-Sen University (7) · Memorial Sloan Kettering Cancer Center (2) · Brii Biosciences Limited (1) · National Cancer Institute (NCI) (1) · Xiamen Amoytop Biotech Co., Ltd. (1) · Merck Sharp & Dohme LLC (1) · European Organisation for Research and Treatment of Cancer - EORTC (1)

Often tested with

Tested in the same studies.

BRII-179 (1) · Elebsiran (1) · Peginterferon alfa-2a (1) · Valopicitabine (1) · Tenofovir (1)

Studies

Open first, then newest update. How each study uses Pegylated Interferon Alfa is read from its arms, and is right about nine times in ten.

Testing it · 14

Given in every arm · 4 — Pegylated Interferon Alfa is usual care beside what is tested